ZVRA Operating Cash Flow Growth
Zevra Therapeutics Inc · Operating Cash Flow Growth
ZVRA Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported172.27%period ending
ZVRA TTM Cash from Operations YoY % (-130.33% → 172.27%)
Year-over-year change
High-resolution chart · PNG
ZVRA operating cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 172.2703% | |
| 120.6831% | |
| 97.7062% | |
| 66.418% | |
| 17.5633% | |
| -35.1922% | |
| -107.7382% | |
| -218.5723% | |
| -135.4572% | |
| -136.8366% | |
| -79.1687% | |
| -44.6004% | |
| -111.9181% | |
| -302.065% | |
| -279.2988% | |
| -247.6633% | |
| -194.3563% | |
| 481.1426% | |
| 638.3703% | |
| 357.1141% | |
| 330.9348% | |
| 82.9647% | |
| 91.8313% | |
| 88.8374% | |
| 89.5547% | |
| 71.2859% | |
| 56.2072% | |
| 22.765% | |
| -22.3134% | |
| -35.8087% | |
| -63.7553% | |
| -28.8387% | |
| -20.0137% | |
| -6.3509% | |
| -11.1783% | |
| -35.0109% | |
| -45.2382% | |
| -75.9611% | |
| -46.8917% | |
| -27.3385% | |
| -15.1542% | |
| -13.2072% | |
| -38.121% | |
| -130.3267% |